FdaApplication
ANDA 077337
Identifiers
- fda_app_no: ANDA077337
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2014-05-07 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 1GM;EQ 4MG BASE | TABLET;ORAL |
| ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 1GM;EQ 2MG BASE | TABLET;ORAL |
| ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 500MG;EQ 1MG BASE | TABLET;ORAL |
| ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 500MG;EQ 2MG BASE | TABLET;ORAL |
| ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 500MG;EQ 4MG BASE | TABLET;ORAL |
5 products